CLEC4F and renal carcinoma: Wan et al. found that the global expression of Kcr was downregulated in liver, gastric, and renal carcinomas, while it was upregulated in thyroid, esophagus, colon, pancreas, and lung malignancies by immunohistochemical staining [24].